Literature DB >> 6493157

Gluconeogenesis and phosphate reabsorption in isolated lactate- or pyruvate-perfused rat kidneys.

A D Baines, B D Ross.   

Abstract

Recent experiments suggest that cytoplasmic free NAD inhibits renal phosphate reabsorption and that gluconeogenesis, by increasing NAD concentration, inhibits phosphate reabsorption. To examine these relationships further we measured phosphate reabsorption by isolated kidneys perfused with either lactate or pyruvate. Lactate perfusion increased the ratio of the cytoplasmic redox couple (glycerol-3-phosphate/dihydroxyacetone phosphate) in snap-frozen kidneys 3-fold relative to the ratio with pyruvate perfusion (p less than 0.001). Inulin clearance and fractional phosphate reabsorption were lower with lactate than with pyruvate perfusion. Phosphate reabsorption decreased throughout the lactate perfusion but was constant for 1 h of pyruvate perfusion. Basal and norepinephrine (NE)-stimulated gluconeogenesis were lower with lactate than with pyruvate perfusion. With lactate and pyruvate perfusions, NE induced equal increases in fractional sodium reabsorption, although only with pyruvate perfusion was there increased phosphate reabsorption. In these experiments, oxidative phosphorylation, not cytoplasmic free NAD concentrations, influenced phosphate reabsorption, and NE-stimulated gluconeogenesis was associated with increased phosphate reabsorption.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6493157

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  2 in total

1.  The inhibition of parathyroid-hormone actions on gluconeogenesis and phosphate transport by 3-mercaptopicolinate in rabbit renal proximal tubules.

Authors:  N Yanagawa; O D Jo
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

2.  The effects of acute renal denervation on kidney perfusion and metabolism in experimental septic shock.

Authors:  Emiel Hendrik Post; Fuhong Su; Koji Hosokawa; Fabio Silvio Taccone; Antoine Herpain; Jacques Creteur; Daniel De Backer; Jean-Louis Vincent
Journal:  BMC Nephrol       Date:  2017-05-31       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.